Cargando…
Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers
Pharmaceutical reactivation of lytic cycle of Epstein–Barr virus (EBV) represents a potential therapeutic strategy against EBV-associated epithelial malignancies, e.g., gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). A novel lytic-inducing compound, C7, which exhibits structural similarit...
Autores principales: | Yiu, Stephanie Pei Tung, Hui, Kwai Fung, Choi, Chung King, Kao, Richard Yi Tsun, Ma, Chi Wang, Yang, Dan, Chiang, Alan Kwok Shing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316324/ https://www.ncbi.nlm.nih.gov/pubmed/30544928 http://dx.doi.org/10.3390/cancers10120505 |
Ejemplares similares
-
Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies
por: Choi, Chung King, et al.
Publicado: (2015) -
Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2019) -
Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2020) -
Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib
por: Hui, Kwai Fung, et al.
Publicado: (2018) -
Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)